医学
心肌梗塞
内科学
血脂异常
心脏病学
风险因素
弗雷明翰风险评分
糖尿病
优势比
疾病
内分泌学
作者
John G. Canto,Catarina I. Kiefe,William J. Rogers,Eric D. Peterson,Paul D. Frederick,William J. French,C. Michael Gibson,Charles V. Pollack,Joseph P. Ornato,Robert J. Zalenski,Jan Penney,Alan J. Tiefenbrunn,Philip Greenland,for the NRMI Investigators
出处
期刊:JAMA
[American Medical Association]
日期:2011-11-16
卷期号:306 (19)
被引量:206
标识
DOI:10.1001/jama.2011.1654
摘要
REVIOUS STUDIES HAVE EXAM-2][3][4][5] These studies have included a meta-analysis from 14 international randomized clinical trials, 1 a case-control study, 2 results from 3 epidemiologic cohort studies, 3 a single-center academic institution, 4 and a community-based registry of patients with non-ST-segment elevation MI only. 5In all of these reports, a majority of patients with MI presented with at least 1 of the 4 major modifiable cardiac risk factors (hypertension, smoking, dyslipidemia, and diabetes).However, these studies were limited to specific populations (those selected for clinical trials, cohorts restricted to a certain geographical area [Chicago or Framingham, Massachusetts], or patients with non-ST-segment elevation MI).Most of these studies did not focus on inpatient mortality during hospitalization for first MI.However, a recent study from a quality improvement initiative reported a modest but surprising inverse association between number of CHD risk factors and mortality in patients with non-STsegment elevation MI only. 5e National Registry of Myocardial Infarction (NRMI) represents a large and generalizable communitybased cohort study of patients hospitalized with acute MI.The main objectives of our study were to ascertain the CHD risk factor distribution of pa-
科研通智能强力驱动
Strongly Powered by AbleSci AI